Table 3.4 Reported cases of laboratory-confirmed, chronic hepatitis B virus (HBV) infection, by sex, race/ethnicity, age group, place of birth and case criteria — Emerging Infections Program (EIP) Hepatitis Surveillance Demonstration Sites, 2011

Share
Compartir
Category
CO
No. (%)
CT
No. (%)
MN
No. (%)
NM
No. (%)
NY
State
No. (%)
NY
City
No. (%)
OR
No. (%)
San
Francisco
No. (%)
Total
No. (%)
Sex
Female
67
(43.0)
174
(49.4)
314
(44.4)
24
(38.7)
804
(41.9)
3174
(45.6)
195
(45.9)
444
(48.3)
5196
(45.2)
Male
89
(57.1)
178
(50.6)
391
(55.2)
38
(61.3)
1117
(58.2)
3779
(54.3)
229
(53.9)
475
(51.6)
6296
(54.7)
Missing
0
(0.0)
0
(0.0)
3
(0.4)
0
(0.0)
0
(0.0)
3
(0.0)
1
(0.2)
1
(0.1)
8
(0.1)
Race/Ethnicity*
AI / AN
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
4
(0.2)
1
(0.0)
8
(1.9)
5
(0.5)
18
(0.2)
API
55
(35.3)
141
(40.1)
246
(34.8)
34
(54.8)
577
(30.0)
1218
(17.5)
246
(57.9)
514
(55.9)
3031
(26.4)
Black
25
(16.0)
58
(16.5)
187
(26.4)
4
(6.5)
310
(16.1)
448
(6.4)
24
(5.7)
19
(2.1)
677
(5.9)
White
31
(19.9)
70
(19.9)
39
(5.5)
10
(16.1)
278
(14.5)
125
(1.8)
101
(23.8)
23
(2.5)
677
(5.9)
Hispanic
7
(4.5)
36
(10.2)
5
(0.7)
7
(11.3)
87
(4.5)
109
(1.6)
9
(2.1)
7
(0.8)
267
(2.3)
Other
4
(2.6)
5
(1.4)
12
(1.7)
0
(0.0)
31
(1.6)
29
(0.4)
0
(0.0)
6
(0.7)
87
(0.8)
Unknown / Missing
34
(21.8)
42
(11.9)
219
(30.9)
7
(11.3)
634
(33.0)
5026
(72.3)
37
(8.7)
346
(37.6)
6345
(55.1)
Age group (yrs)
0-14
6
(3.9)
3
(0.9)
35
(4.9)
2
(3.2)
27
(1.4)
55
(0.8)
19
(4.5)
4
(0.4)
151
(1.3)
15-24
17
(10.9)
20
(5.7)
114
(16.1)
6
(9.7)
123
(6.4)
670
(9.6)
20
(4.7)
28
(3.0)
998
(8.7)
25-39
67
(43.0)
154
(33.8)
291
(41.1)
15
(24.2)
553
(28.8)
2859
(41.1)
161
(37.9)
238
(25.9)
4338
(37.7)
40-54
44
(28.2)
103
(29.3)
169
(23.9)
22
(35.5)
735
(38.3)
2206
(31.7)
143
(33.7)
328
(35.7)
3750
(32.6)
55+
22
(14.1)
72
(20.5)
99
(14.0)
17
(27.4)
483
(25.1)
1166
(16.8)
82
(19.3)
322
(35.0)
2263
(19.7)
Missing
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
0
(0.0)
Place of Birth
United States
14
(9.0)
40
(11.4)
25
(3.5)
U
(U)
125
(6.5)
10
(0.1)
81
(19.1)
12
(1.3)
307
(2.7)
Outside US
77
(49.4)
147
(41.8)
218
(30.8)
U
(U)
1796
(93.5)
176
(2.5)
198
(46.6)
104
(11.3)
2981
(25.9)
Missing/
Unknown
65
(41.7)
147
(41.8)
218
(30.8)
U
(U)
0
(0.0)
6770
(97.3)
146
(34.4)
804
(87.4)
8150
(70.9)
Positive Laboratory Tests†
HBV surface antigen
148
(94.9)
350
(99.4)
686
(96.9)
U
(U)
1865
(97.1)
6642
(95.5)
381
(89.7)
830
(90.2)
10902
(94.8)
HBV “e” antigen
25
(16.0)
51
(14.5)
184
(26.0)
U
(U)
365
(19.0)
1379
(19.8)
83
(19.5)
117
(12.7)
2204
(19.2)
HBV-DNA
64
(41.0)
131
(37.2)
464
(65.5)
U
(U)
1294
(67.4)
5487
(78.9)
163
(38.4)
629
(68.4)
8232
(71.6)
Total new
reported cases
156 352 708 62 1,921 6,956 425 920 11,500
Estimated 2010
population
5,116,796 3,580,709 5,344,861 2,082,224 11,220,287 8,175,133 3,871,826 812,826 40,274,472
Rate per 100,000 population
3.0 9.8 13.2 3.0 17.1 84.4 11.0 113.2 28.6

*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting